A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Phase 4
80
about 2.3 years
18–65
1 site in NY
About this study
Researchers are testing whether Rimegepant (Nurtec) is more effective than Rizatriptan (Maxalt) for treating migraines in adults who go to the Emergency Department. The trial will last 851 days and involve approximately 80 patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Rimegepant
- 2.Take Rizatriptan Benzoate
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
rimegepant, Antimigraine Agents (Serotonin 1b Receptor Agonists)
oral (Disintegrating Oral Tablet), oral (Oral Tablet)
Primary: Change in Pain Score at 60 minutes
Secondary: Change in Pain Score, Functional Status, Headache Medication Efficacy and Tolerability Perception by the Patient
Neurology